Literature DB >> 21642541

NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection.

Lei Jiao1, Xiaoling Gao, Antony George Joyee, Lei Zhao, Hongyu Qiu, Megan Yang, Yijun Fan, Shuhe Wang, Xi Yang.   

Abstract

Dendritic cells (DC) play a key role in establishing protective adaptive immunity in intracellular bacterial infections, but the cells influencing DC function in vivo remain unclear. In this study, we investigated the role of NK cells in modulating the function of DC using a murine Chlamydia infection model. We found that the NK cell-depleted mice showed exacerbated disease after respiratory tract Chlamydia muridarum infection, which was correlated with altered T cell cytokine profile. Furthermore, DC from C. muridarum-infected NK-depleted mice (NK(-)DC) exhibited a less mature phenotype compared with that of DC from the infected mice without NK depletion (NK(+)DC). NK(-)DC produced significantly lower levels of both IL-12 and IL-10 than those of NK(+)DC. Moreover, NK(-)DC showed reduced ability to direct primary and established Ag-specific Th1 CD4(+) T cell responses in DC-T coculture systems. More importantly, adoptive transfer of NK(-)DC, in contrast to NK(+)DC, failed to induce type 1 protective immunity in recipients after challenge infection. Finally, NK cells showed strong direct enhancing effect on IL-12 production by DC in an NK-DC coculture system, which was partially reduced by blocking NKG2D receptors signaling and virtually abolished by neutralizing IFN-γ activity. The data demonstrate a critical role of NK cells in modulating DC function in an intracellular bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642541     DOI: 10.4049/jimmunol.1002519

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

Review 2.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 3.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

4.  Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.

Authors:  Xiaoling Gao; Lei Zhao; Shuhe Wang; Jie Yang; Xi Yang
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

5.  Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator.

Authors:  M-C Chang; Y-L Chen; Y-C Chiang; T-C Chen; Y-C Tang; C-A Chen; W-Z Sun; W-F Cheng
Journal:  Gene Ther       Date:  2015-08-11       Impact factor: 5.250

6.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 7.  Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology.

Authors:  Gérard Eberl; Marco Colonna; James P Di Santo; Andrew N J McKenzie
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

8.  IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence.

Authors:  Sanja Mandaric; Senta M Walton; Thomas Rülicke; Kirsten Richter; Mathilde J H Girard-Madoux; Björn E Clausen; Antonija Zurunic; Masahito Kamanaka; Richard A Flavell; Stipan Jonjic; Annette Oxenius
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

Review 9.  T cell responses to Chlamydia.

Authors:  Jennifer D Helble; Michael N Starnbach
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.166

10.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.